The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial.

Shaohui Chen, Jin Wang, Xiaohan Xu, Yuguang Huang, Shanfu Xue, Anshi Wu, Xiaoju Jin, Qiang Wang, Jianrui Lyu, Sheng Wang,

PubMed · 2020 · 162 citations · 10 references

Full text

Open access

Concepts

Abstract

<0.001) were less frequent in remimazolam group compared with propofol group. In conclusion, remimazolam tosylate is non-inferior in sedation efficacy while safer than propofol in patients undergoing colonoscopy.

References

10